Direct gene therapy for repair of the spinal cord

Bas Blits, Mary B Bunge

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

For regrowth of injured nerve fibers following spinal cord injury (SCI), the environment must be favorable for axonal growth. The delivery of a therapeutic gene, beneficial for axonal growth, into the central nervous system for repair can be accomplished in many ways. Perhaps the most simple and elegant strategy is the so-called direct gene therapy approach that uses a single injection for delivery of a gene therapy vehicle. Among the vectors that have been used to transduce neural tissue in vivo are non-viral, herpes simplex viral, adeno-associated viral, adenoviral, and lentiviral vectors, each with their own merits and limitations. Many studies have been undertaken using direct gene therapy, ranging from strategies for neuroprotection to axonal growth promotion at the injury site, dorsal root injury repair, and initiation of a growth-supporting genetic program. The limitations and successes of direct gene transfer for spinal cord repair are discussed in this review.

Original languageEnglish
Pages (from-to)508-520
Number of pages13
JournalJournal of Neurotrauma
Volume23
Issue number3-4
DOIs
StatePublished - Mar 1 2006

Fingerprint

Spinal Cord Regeneration
Genetic Therapy
Growth
Herpes Simplex
Spinal Nerve Roots
Wounds and Injuries
Spinal Cord Injuries
Nerve Fibers
Genes
Central Nervous System
Injections

Keywords

  • CNS
  • Delivery
  • Growth factor
  • Spinal cord injury
  • Transgene
  • Viral vector

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Direct gene therapy for repair of the spinal cord. / Blits, Bas; Bunge, Mary B.

In: Journal of Neurotrauma, Vol. 23, No. 3-4, 01.03.2006, p. 508-520.

Research output: Contribution to journalArticle

Blits, Bas ; Bunge, Mary B. / Direct gene therapy for repair of the spinal cord. In: Journal of Neurotrauma. 2006 ; Vol. 23, No. 3-4. pp. 508-520.
@article{8d28efcb6d8a452dab979a8a34c212e0,
title = "Direct gene therapy for repair of the spinal cord",
abstract = "For regrowth of injured nerve fibers following spinal cord injury (SCI), the environment must be favorable for axonal growth. The delivery of a therapeutic gene, beneficial for axonal growth, into the central nervous system for repair can be accomplished in many ways. Perhaps the most simple and elegant strategy is the so-called direct gene therapy approach that uses a single injection for delivery of a gene therapy vehicle. Among the vectors that have been used to transduce neural tissue in vivo are non-viral, herpes simplex viral, adeno-associated viral, adenoviral, and lentiviral vectors, each with their own merits and limitations. Many studies have been undertaken using direct gene therapy, ranging from strategies for neuroprotection to axonal growth promotion at the injury site, dorsal root injury repair, and initiation of a growth-supporting genetic program. The limitations and successes of direct gene transfer for spinal cord repair are discussed in this review.",
keywords = "CNS, Delivery, Growth factor, Spinal cord injury, Transgene, Viral vector",
author = "Bas Blits and Bunge, {Mary B}",
year = "2006",
month = "3",
day = "1",
doi = "10.1089/neu.2006.23.508",
language = "English",
volume = "23",
pages = "508--520",
journal = "Journal of Neurotrauma",
issn = "0897-7151",
publisher = "Mary Ann Liebert Inc.",
number = "3-4",

}

TY - JOUR

T1 - Direct gene therapy for repair of the spinal cord

AU - Blits, Bas

AU - Bunge, Mary B

PY - 2006/3/1

Y1 - 2006/3/1

N2 - For regrowth of injured nerve fibers following spinal cord injury (SCI), the environment must be favorable for axonal growth. The delivery of a therapeutic gene, beneficial for axonal growth, into the central nervous system for repair can be accomplished in many ways. Perhaps the most simple and elegant strategy is the so-called direct gene therapy approach that uses a single injection for delivery of a gene therapy vehicle. Among the vectors that have been used to transduce neural tissue in vivo are non-viral, herpes simplex viral, adeno-associated viral, adenoviral, and lentiviral vectors, each with their own merits and limitations. Many studies have been undertaken using direct gene therapy, ranging from strategies for neuroprotection to axonal growth promotion at the injury site, dorsal root injury repair, and initiation of a growth-supporting genetic program. The limitations and successes of direct gene transfer for spinal cord repair are discussed in this review.

AB - For regrowth of injured nerve fibers following spinal cord injury (SCI), the environment must be favorable for axonal growth. The delivery of a therapeutic gene, beneficial for axonal growth, into the central nervous system for repair can be accomplished in many ways. Perhaps the most simple and elegant strategy is the so-called direct gene therapy approach that uses a single injection for delivery of a gene therapy vehicle. Among the vectors that have been used to transduce neural tissue in vivo are non-viral, herpes simplex viral, adeno-associated viral, adenoviral, and lentiviral vectors, each with their own merits and limitations. Many studies have been undertaken using direct gene therapy, ranging from strategies for neuroprotection to axonal growth promotion at the injury site, dorsal root injury repair, and initiation of a growth-supporting genetic program. The limitations and successes of direct gene transfer for spinal cord repair are discussed in this review.

KW - CNS

KW - Delivery

KW - Growth factor

KW - Spinal cord injury

KW - Transgene

KW - Viral vector

UR - http://www.scopus.com/inward/record.url?scp=33646576504&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646576504&partnerID=8YFLogxK

U2 - 10.1089/neu.2006.23.508

DO - 10.1089/neu.2006.23.508

M3 - Article

VL - 23

SP - 508

EP - 520

JO - Journal of Neurotrauma

JF - Journal of Neurotrauma

SN - 0897-7151

IS - 3-4

ER -